IBM announces upcoming addition of Dr Martha Pollack to its Board of Directors

– USA, NY –  IBM (NYSE:IBM) today announced that its board of directors elected Martha E. Pollack to the board, effective February 1, 2019.

Ginni Rometty, IBM chairman, president and chief executive officer, said: “Martha Pollack is a renowned AI researcher and technologist and an expert in AI. We are excited about adding her skills and expertise to the IBM board. Her perspective on education and the use of technology to improve lives will be great assets to IBM and to our shareholders.”

About Martha Pollack

Dr. Pollack is the 14th president of Cornell University. She is a computer scientist and a leader in the field of artificial intelligence. Dr. Pollack joined Cornell in 2017 after serving for more than three years as the provost and executive vice president of academic affairs at the University of Michigan, where she had previously served as vice provost and as a dean.

Dr. Pollack has published extensively on artificial intelligence, on topics ranging from natural-language processing to automated planning and temporal reasoning. Her research has had a significant focus on the design of AI technologies to assist people with cognitive impairment. Dr. Pollack has been a senior computer scientist at the Artificial Intelligence Center for SRI International, Inc. and served as director of the University of Pittsburgh’s Intelligent Systems Program prior to joining the University of Michigan in 2000.

Dr. Pollack holds a bachelor’s degree from Dartmouth College and a master’s degree in computer and information science from the University of Pennsylvania, where she also earned her PhD in 1986.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.